Patents by Inventor Celine Vanderplanck

Celine Vanderplanck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Agents useful in treating facioscapulohumeral muscular dystrophy
    Patent number: 11898143
    Abstract: Antisense agents and RNA interference agents useful for treating diseases and conditions the treatment of which can benefit from reducing the expression of double homeobox 4 and/or double homeobox 4c, more particularly facioscapulohumeral muscular dystrophy. Methods, uses and further products employing such agents are also described.
    Type: Grant
    Filed: January 20, 2021
    Date of Patent: February 13, 2024
    Assignee: Universite de Mons
    Inventors: Alexandra Belayew, Frederique Coppee, Celine Vanderplanck, Stephen Donald Wilton, Eugenie Ansseau
  • AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    Publication number: 20210163941
    Abstract: Antisense agents and RNA interference agents useful for treating diseases and conditions the treatment of which can benefit from reducing the expression of double homeobox 4 and/or double homeobox 4c, more particularly facioscapulohumeral muscular dystrophy. Methods, uses and further products employing such agents are also described.
    Type: Application
    Filed: January 20, 2021
    Publication date: June 3, 2021
    Inventors: Alexandra Belayew, Frederique Coppee, Celine Vanderplanck, Stephen Donald Wilton, Eugenie Ansseau
  • AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    Publication number: 20210163942
    Abstract: Antisense agents and RNA interference agents useful for treating diseases and conditions the treatment of which can benefit from reducing the expression of double homeobox 4 and/or double homeobox 4c, more particularly facioscapulohumeral muscular dystrophy. Methods, uses and further products employing such agents are also described.
    Type: Application
    Filed: January 20, 2021
    Publication date: June 3, 2021
    Inventors: Alexandra Belayew, Frederique Coppee, Celine Vanderplanck, Stephen Donald Wilton, Eugenie Ansseau
  • Agents useful in treating facioscapulohumeral muscular dystrophy
    Patent number: 10907157
    Abstract: Antisense agents and RNA interference agents useful for treating diseases and conditions the treatment of which can benefit from reducing the expression of double homeobox 4 and/or double homeobox 4c, more particularly facioscapulohumeral muscular dystrophy, are described. Methods, uses and further products employing such agents are also described.
    Type: Grant
    Filed: September 5, 2019
    Date of Patent: February 2, 2021
    Assignee: Université de Mons
    Inventors: Alexandra Belayew, Frederique Coppee, Celine Vanderplanck, Stephen Donald Wilton, Eugenie Ansseau
  • AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    Publication number: 20200231966
    Abstract: Antisense agents and RNA interference agents useful for treating diseases and conditions the treatment of which can benefit from reducing the expression of double homeobox 4 and/or double homeobox 4c, more particularly facioscapulohumeral muscular dystrophy. Methods, uses and further products employing such agents are also described.
    Type: Application
    Filed: September 5, 2019
    Publication date: July 23, 2020
    Inventors: Alexandra Belayew, Frederique Coppee, Celine Vanderplanck, Stephen Donald Wilton, Eugenie Ansseau
  • AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    Publication number: 20180265870
    Abstract: The invention teaches antisense agents and RNA interference agents useful for treating diseases and conditions the treatment of which can benefit from reducing the expression of double homeobox 4 and/or double homeobox 4c, more particularly facioscapulohumeral muscular dystrophy. Further elaborated are methods, uses and further products employing such agents.
    Type: Application
    Filed: January 17, 2018
    Publication date: September 20, 2018
    Inventors: Alexandra Belayew, Frederique Coppee, Celine Vanderplanck, Stephen Donald Wilton, Eugenie Ansseau
  • Agents useful in treating facioscapulohumeral muscular dystrophy
    Patent number: 9988628
    Abstract: The invention teaches antisense agents and RNA interference agents useful for treating diseases and conditions the treatment of which can benefit from reducing the expression of double homeobox 4 and/or double homeobox 4c, more particularly facioscapulohumeral muscular dystrophy. Further elaborated are methods, uses and further products employing such agents.
    Type: Grant
    Filed: February 18, 2016
    Date of Patent: June 5, 2018
    Assignee: UNIVERSITE DE MONS
    Inventors: Alexandra Belayew, Frederique Coppee, Celine Vanderplanck, Stephen Donald Wilton, Eugenie Ansseau
  • AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    Publication number: 20170029814
    Abstract: The invention teaches antisense agents and RNA interference agents useful for treating diseases and conditions the treatment of which can benefit from reducing the expression of double homeobox 4 and/or double homeobox 4c, more particularly facioscapulohumeral muscular dystrophy. Further elaborated are methods, uses and further products employing such agents.
    Type: Application
    Filed: February 18, 2016
    Publication date: February 2, 2017
    Inventors: Alexandra Belayew, Frederique Coppee, Celine Vanderplanck, Stephen Donald Wilton, Eugenie Ansseau
  • AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    Publication number: 20140105873
    Abstract: The invention teaches antisense agents and RNA interference agents useful for treating diseases and conditions the treatment of which can benefit from reducing the expression of double homeobox 4 and/or double homeobox 4c, more particularly facioscapulohumeral muscular dystrophy. Further elaborated are methods, uses and further products employing such agents.
    Type: Application
    Filed: November 12, 2013
    Publication date: April 17, 2014
    Applicant: Universite de Mons
    Inventors: Alexandra Belayew, Frederique Coppee, Celine Vanderplanck, Donald Stephen Wilton, Eugenie Ansseau
  • AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
    Publication number: 20120225034
    Abstract: The invention teaches antisense agents and RNA interference agents useful for treating diseases and conditions the treatment of which can benefit from reducing the expression of double homeobox 4 and/or double homeobox 4c, more particularly facioscapulohumeral muscular dystrophy. Further elaborated are methods, uses and further products employing such agents.
    Type: Application
    Filed: September 2, 2011
    Publication date: September 6, 2012
    Applicant: Universite de Mons
    Inventors: Alexandra Belayew, Frédérique Coppée, Céline Vanderplanck, Stephen Donald Wilton, Eugénie Ansseau